Recognizing life-threatening causes of syncope

Cardiology Clinics

Volumn 31, Issue 1, 2013, Pages 51-66

  Khoo, Clarence ^a   Chakrabarti, Santabhanu ^a   Arbour, Laura ^a   Krahn, Andrew D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiac arrest; Clinical history; Family history; Repolarization; Risk; Structural heart disease; Syncope; Ventricular arrhythmia

Indexed keywords

POTASSIUM CHANNEL KCNQ1;

ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BRADYCARDIA; BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CLINICAL ASSESSMENT; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TEST; FAINTNESS; HEART ARREST; HEART ARRHYTHMIA; HEART FUNCTION TEST; HEART PAPILLARY MUSCLE; HEART REPOLARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART TAMPONADE; HEART VENTRICLE SEPTUM RUPTURE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SHORT QT SYNDROME; SINUS NODE DISEASE; THREAT; WOLFF PARKINSON WHITE SYNDROME;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CRITICAL ILLNESS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; MEDICAL HISTORY TAKING; PROGNOSIS; RISK FACTORS; SYNCOPE;

EID: 84870536207     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2012.10.005     Document Type: Review

References (69)

1. Angaran P., Klein G.J., Yee R., et al. Syncope. Neurol Clin 2011, 29(4):903-925.
2. Kapoor W.N., Karpf M., Wieand S., et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983, 309(4):197-204.
3. Soteriades E.S., Evans J.C., Larson M.G., et al. Incidence and prognosis of syncope. N Engl J Med 2002, 347(12):878-885.
4. Ganzeboom K.S., Mairuhu G., Reitsma J.B., et al. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 2006, 17(11):1172-1176.
5. Kapoor W.N. Evaluation and outcome of patients with syncope. Medicine 1990, 69(3):160-175.
6. Eagle K.A., Black H.R., Cook E.F., et al. Evaluation of prognostic classifications for patients with syncope. Am J Med 1985, 79(4):455-460.
7. Mitro P., Kirsch P., Valocik G., et al. A prospective study of the standardized diagnostic evaluation of syncope. Europace 2011, 13(4):566-571.
8. Baron-Esquivias G., Errazquin F., Pedrote A., et al. Long-term outcome of patients with vasovagal syncope. Am Heart J 2004, 147(5):883-889.
9. Olshansky B., Poole J.E., Johnson G., et al. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol 2008, 51(13):1277-1282.
10. Ungar A., Del Rosso A., Giada F., et al. Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study. Eur Heart J 2010, 31(16):2021-2026.
11. Calkins H., Shyr Y., Frumin H., et al. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med 1995, 98(4):365-373.
12. Moya A., Sutton R., Ammirati F., et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009, 30(21):2631-2671.
13. Barold S.S., Hayes D.L. Second-degree atrioventricular block: a reappraisal. Mayo Clin Proc 2001, 76(1):44-57.
14. Greenberg H., McMaster P., Dwyer E.M. Left ventricular dysfunction after acute myocardial infarction: results of a prospective multicenter study. J Am Coll Cardiol 1984, 4(5):867-874.
15. Buxton A.E., Lee K.L., Hafley G.E., et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 2007, 50(12):1150-1157.
16. Bokil N.J., Baisden J.M., Radford D.J., et al. Molecular genetics of long QT syndrome. Mol Genet Metab 2010, 101(1):1-8.
17. Schwartz P.J., Stramba-Badiale M., Crotti L., et al. Prevalence of the congenital long-QT syndrome. Circulation 2009, 120(18):1761-1767.
18. Sy R.W., van der Werf C., Chattha I.S., et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 2011, 124(20):2187-2194.
19. Wong J.A., Gula L.J., Klein G.J., et al. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol 2010, 3(2):120-125.
20. Goldenberg I., Moss A.J. Long QT syndrome. J Am Coll Cardiol 2008, 51(24):2291-2300.
21. Schwartz P.J., Moss A.J., Vincent G.M., et al. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993, 88(2):782-784.
22. Colman N., Bakker A., Linzer M., et al. Value of history-taking in syncope patients: in whom to suspect long QT syndrome?. Europace 2009, 11(7):937-943.
23. Priori S.G., Cerrone M. Genetic arrhythmias. Ital Heart J 2005, 6(3):241-248.
24. Sarkozy A., Brugada P. Sudden cardiac death: what is inside our genes?. Can J Cardiol 2005, 21(12):1099-1110.
25. Lehnart S.E., Ackerman M.J., Benson D.W., et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007, 116(20):2325-2345.
26. Gollob M.H., Redpath C.J., Roberts J.D. The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol 2011, 57(7):802-812.
27. Lippi G., Montagnana M., Meschi T., et al. Genetic and clinical aspects of Brugada syndrome: an update. Adv Clin Chem 2012, 56:197-208.
28. Nademanee K., Veerakul G., Nimmannit S., et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997, 96(8):2595-2600.
29. Miyasaka Y., Tsuji H., Yamada K., et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 2001, 38(3):771-774.
30. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005, 111(5):659-670.
31. Sangwatanaroj S., Prechawat S., Sunsaneewitayakul B., et al. New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J 2001, 22(24):2290-2296.
32. Priori S.G., Napolitano C., Memmi M., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002, 106(1):69-74.
33. Sy R.W., Gollob M.H., Klein G.J., et al. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2011, 8(6):864-871.
34. Napolitano C., Priori S.G. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007, 4(5):675-678.
35. Klein G.J., Bashore T.M., Sellers T.D., et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979, 301(20):1080-1085.
36. Haissaguerre M., Derval N., Sacher F., et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008, 358(19):2016-2023.
37. Rosso R., Kogan E., Belhassen B., et al. J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol 2008, 52(15):1231-1238.
38. Tikkanen J.T., Anttonen O., Junttila M.J., et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009, 361(26):2529-2537.
39. Stern S. Clinical aspects of the early repolarization syndrome: a 2011 update. Ann Noninvasive Electrocardiol 2011, 16(2):192-195.
40. Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 124(24):2761-2796.
41. Marian A.J. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 2010, 40(4):360-369.
42. Towbin J.A. Hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2009, 32(Suppl 2):S23-S31.
43. Basso C., Corrado D., Marcus F.I., et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009, 373(9671):1289-1300.
44. Sen-Chowdhry S., Syrris P., Ward D., et al. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007, 115(13):1710-1720.
45. Corrado D., Fontaine G., Marcus F.I., et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation. Circulation 2000, 101(11):E101-E106.
46. Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010, 121(13):1533-1541.
47. Cox M.G., Nelen M.R., Wilde A.A., et al. Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria. J Cardiovasc Electrophysiol 2008, 19(8):775-781.
48. Jain R., Dalal D., Daly A., et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation 2009, 120(6):477-487.
49. Kamath G.S., Zareba W., Delaney J., et al. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2011, 8(2):256-262.
50. Fontaine G., Fontaliran F., Hebert J.L., et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Med 1999, 50:17-35.
51. Krahn A.D., Klein G.J., Yee R., et al. The use of monitoring strategies in patients with unexplained syncope-role of the external and implantable loop recorder. Clin Auton Res 2004, 14(Suppl 1):55-61.
52. Moya A., Garcia-Civera R., Croci F., et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J 2011, 32(12):1535-1541.
53. Quinn J., McDermott D., Stiell I., et al. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med 2006, 47(5):448-454.
54. Colivicchi F., Ammirati F., Melina D., et al. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J 2003, 24(9):811-819.
55. Serrano L.A., Hess E.P., Bellolio M.F., et al. Accuracy and quality of clinical decision rules for syncope in the emergency department: a systematic review and meta-analysis. Ann Emerg Med 2010, 56(4):362-373.e1.
56. Saccilotto R.T., Nickel C.H., Bucher H.C., et al. San Francisco Syncope Rule to predict short-term serious outcomes: a systematic review. CMAJ 2011, 183(15):E1116-E1126.
57. Martin T.P., Hanusa B.H., Kapoor W.N. Risk stratification of patients with syncope. Ann Emerg Med 1997, 29(4):459-466.
58. Del Rosso A., Ungar A., Maggi R., et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart 2008, 94(12):1620-1626.
59. Sun B.C., Derose S.F., Liang L.J., et al. Predictors of 30-day serious events in older patients with syncope. Ann Emerg Med 2009, 54(6):769-778.e1-5.
60. Galizia G., Abete P., Mussi C., et al. Role of early symptoms in assessment of syncope in elderly people: results from the Italian group for the study of syncope in the elderly. J Am Geriatr Soc 2009, 57(1):18-23.
61. Mitro P., Kirsch P., Valocik G., et al. Clinical history in the diagnosis of the cardiac syncope-the predictive scoring system. Pacing Clin Electrophysiol 2011, 34(11):1480-1485.
62. Wayne H.H. Syncope. Physiological considerations and an analysis of the clinical characteristics in 510 patients. Am J Med 1961, 30:418-438.
63. Pomerantz B., O'Rourke R.A. The Stokes-Adams syndrome. Am J Med 1969, 46(6):941-960.
64. Krahn A.D., Healey J.S., Simpson C.S., et al. Sentinel symptoms in patients with unexplained cardiac arrest: from the cardiac arrest survivors with preserved ejection fraction registry (CASPER). J Cardiovasc Electrophysiol 2012, 23(1):60-66.
65. Del Rosso A., Alboni P., Brignole M., et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol 2005, 96(10):1431-1435.
66. Tavora F., Zhang M., Franco M., et al. Distribution of biventricular disease in arrhythmogenic cardiomyopathy: an autopsy study. Hum Pathol 2012, 43(4):592-596.
67. Bhonsale A., James C.A., Tichnell C., et al. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol 2011, 58(14):1485-1496.
68. Recchia D., Barzilai B. Echocardiography in the evaluation of patients with syncope. J Gen Intern Med 1995, 10(12):649-655.
69. Linzer M., Yang E.H., Estes N.A., et al. Diagnosing syncope. Part 2: unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997, 127(1):76-86.